Race Oncology 2025 AGM: CEO Presentation + Q&A Recording
Watch the highlights from Race Oncology’s 2025 Annual General Meeting, including the CEO Presentation from Dr Daniel Tillett and an interactive Q&A session with the audience following the forma proceedings.
The CEO Presentation included:
- The importance of MOA discoveries
- Progress on key clinical programs
- Intellectual property milestones
- Funding outlook and pathways to accelerated approvals
Race Oncology is driving innovation to tackle some of oncology’s toughest challenges. Watch now to learn how we’re shaping the future of cancer treatment. Subscribe for more updates on our clinical progress and strategic developments.
Watch here: https://youtu.be/9Ee6rxv-_ww
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Racura Oncology. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Racura Oncology a question about this update.